New Delhi: Asserting {that a} “step-by-step” strategy was adopted in direction of contracts and regulatory approvals throughout an eight-month-long course of, pharmaceutical firm Bharat Biotech has clarified that it had not obtained any cost from the Brazilian authorities to this point.
The pharmaceutical firm’s assertion got here following a brief suspension of a cope with Brazil for 20 million doses of the Covaxin Covid-19 vaccine.
“As of 29th June 2021, Bharat Biotech has not obtained any advance funds nor equipped any vaccines to Ministry of Well being Brazil,” the corporate stated in an announcement.
“The pricing of Covaxin has been clearly established between $15-20 per dose for provides to governments exterior India. The pricing for Brazil has additionally been indicated at $15 per dose,” PTI quoted the corporate as saying with regard to the pricing of the doses.
Bharat Biotech additional stated a “related strategy in direction of contracts, regulatory approvals, and provides in a number of nations worldwide, the place Covaxin is being equipped efficiently”.
The Hyderabad-based pharmaceutical firm had on June four obtained emergency use approval in Brazil.
This got here after the Nationwide Well being Surveillance Company of Brazil- Anvisa, allowed import of the Covid-19 vaccine with sure circumstances.
Brazil Well being Minister Marcelo Queiroga, nevertheless, on Wednesday introduced that the corporate had briefly suspended its cope with Bharat Biotech following allegations of irregularities within the deal.
Try beneath Well being Instruments-
Calculate Your Body Mass Index ( BMI )
Calculate The Age Through Age Calculator
Source link
